Tuesday, June 9, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Chemicals

Thyssenkrupp’s Two-Speed Recovery: Green Ammonia Wins as Steel Bleeds Red

SiterGedge by SiterGedge
April 24, 2026
in Chemicals, Hydrogen, Industrial, Renewable Energy
0
Thyssenkrupp Stock
0
SHARES
21
VIEWS
Share on FacebookShare on Twitter

The Essen-based industrial conglomerate is living a tale of two extremes. While its plant-engineering arm secures a landmark export deal in Southeast Asia, the steel division continues to drag the entire group deeper into the red. With a net loss of €334 million in the first fiscal quarter and a stock that has shed roughly nine percent since January, Thyssenkrupp faces a pivotal test of its ability to execute a radical transformation.

A Fresh Breeze from Brunei

Thyssenkrupp Uhde, the group’s engineering subsidiary, has clinched a contract with Brunei Fertilizer Industries to expand ammonia export capacity. The project involves constructing a new cooling tank and a modern ship-loading facility, designed to enable large-scale shipments into global markets. Ammonia is gaining traction as a carrier for green hydrogen, positioning this contract as a strategic win for the group’s long-term decarbonisation ambitions.

Yet the hydrogen story is not all smooth sailing. Thyssenkrupp Nucera, the electrolyser unit, issued a profit warning in March after a US customer cancelled a pilot plant agreement. Additional cost overruns in the green hydrogen segment compounded the pain, though a new electrolyser order from Spanish energy group Moeve has offered some respite for the current fiscal year.

Steel’s Deepening Wounds

The core problem remains the steel division. Cheap Asian imports have flooded the European Union — volumes have tripled since 2022 — crushing margins and forcing drastic measures. After months of short-time work, Thyssenkrupp will shutter its Isbergues site in France for several months this summer. The financial toll is stark: first-quarter revenue slid to €7.2 billion, while adjusted operating profit improved slightly to €211 million, but restructuring costs in steel drove the overall net loss.

Management is pursuing an exit from the HKM steel joint venture, with a sale of its stake to Salzgitter AG targeted for June. Meanwhile, negotiations with Indian rival Jindal Steel remain tense. A breakdown of those talks would throw the entire future of the steel business into doubt, analysts warn.

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

A Hidden Ace in the Elevator Shaft

Outside the struggling core operations, Thyssenkrupp still holds a roughly 16 percent stake in TK Elevator. The majority owners are exploring an initial public offering, with five major banks already preparing the listing. At a potential valuation of up to €25 billion for the entire elevator business, Thyssenkrupp’s stake could be worth around €4 billion. A direct sale is also on the table, though antitrust concerns over market concentration could complicate that route.

Brussels to the Rescue?

Relief for the beleaguered steel division may come from European regulators. The EU Parliament is set to vote by the end of June on doubling existing steel tariffs, with a decision on additional safeguard duties expected on July 1. That timeline places significant weight on the half-year results due May 12, which will provide hard data on the group’s current earnings trajectory.

Technical and Market Signals

Investor sentiment remains cautious. Thyssenkrupp shares slipped below the 200-day moving average recently, trading around €8.79 to €8.90, establishing a medium-term downtrend. The relative strength index hovers near 31, technically close to oversold territory. Barclays continues to recommend underweighting the stock.

The next few months will demand deft navigation from management: completing the costly steel restructuring, delivering on the new plant-engineering orders profitably, and closing the HKM sale. If the elevator IPO materialises, it could provide a much-needed cash injection. But for now, the group’s transformation remains a race between green shoots in engineering and the heavy anchor of steel.

Ad

Thyssenkrupp Stock: Buy or Sell?! New Thyssenkrupp Analysis from June 9 delivers the answer:

The latest Thyssenkrupp figures speak for themselves: Urgent action needed for Thyssenkrupp investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 9.

Thyssenkrupp: Buy or sell? Read more here...

Tags: Thyssenkrupp
SiterGedge

SiterGedge

Related Posts

Ballard Power Stock
Analysis

Ballard Power: 99% Board Support and Project Forge’s Cost Overhaul Amid 18% Weekly Slide

June 8, 2026
Bayer Stock
Analysis

Bayer’s Technical Battle at the 200-Day Line Gets Reinforcement from Agriculture AI and Kidney Drug Progress

June 8, 2026
Rheinmetall Stock
Defense & Aerospace

A €5 Million Vote of Confidence: Rheinmetall’s CEO Buys Shares as the Company Sheds Civilian Assets and Banks €1 Billion in Bundeswehr Orders

June 8, 2026
Next Post
Deutsche Telekom Stock

Deutsche Telekom’s Q1 Report Looms as Merger Talk and Technical Weakness Collide

SAP Stock

SAP Shares Stage a Sharp Reversal After Q1 Numbers Crush Estimates

ABO WIND AG Stock

ABO Energy’s Creditor Lifeline Masks the Scale of a €170 Million Wreckage

Recommended

Finance_ Stock Charts (2)

Elyse Greenspan Downgrades Chubb from Overweight to EqualWeight Rating

2 years ago
Morningstar Stock

Shifting Tides at Morningstar: Insider Sales and Short Covering Raise Questions

10 months ago
Gerresheimer Stock

Gerresheimer Stock: Leadership Shake-Up Sparks Investor Watch

10 months ago
Gossamer Bio Stock

Gossamer Bio Shares Face Pressure After Clinical Trial Setback

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Where Big Money Flees: Inside DroneShield’s Strange Tug-of-War

Novo Nordisk’s 15 Billion Kroner Buyback Sends a Message, but the Market Isn’t Listening

ServiceNow’s 22% Revenue Surge and AI Compliance Deal Can’t Soothe a Volatile Market

Commerzbank’s Three-Week Pressure Point: Rates, Regulation, and a Takeover Deadline

Meta Blends Storefront Ambitions with Workforce Training as AI Costs Surge Past $145 Billion

Marvell’s AI Makeover Gets a Passive Boost: S&P 500 Entry Meets a 38,000% Gap Between High and Low

Trending

BioNTech Stock
Nasdaq

BioNTech’s Oncology Data Wows, but the Stock Won’t Budge: A $1 Billion Buyback Meets Investor Skepticism

by Jackson Burston
June 9, 2026
0

The numbers from Chicago were impressive. On May 30, BioNTech and Bristol Myers Squibb unveiled interim Phase...

Microsoft Stock

Microsoft’s Twin Challenges: Stemming a Game Pass Exodus While Bankrolling a $190 Billion AI Bet

June 9, 2026
D-Wave Quantum Stock

D-Wave Quantum: Tangible Physics Validation and a Gate-Model Roadmap – The Credibility Gap Narrows, But Volatility Endures

June 9, 2026
DroneShield Stock

Where Big Money Flees: Inside DroneShield’s Strange Tug-of-War

June 9, 2026
Novo Nordisk Stock

Novo Nordisk’s 15 Billion Kroner Buyback Sends a Message, but the Market Isn’t Listening

June 9, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Oncology Data Wows, but the Stock Won’t Budge: A $1 Billion Buyback Meets Investor Skepticism
  • Microsoft’s Twin Challenges: Stemming a Game Pass Exodus While Bankrolling a $190 Billion AI Bet
  • D-Wave Quantum: Tangible Physics Validation and a Gate-Model Roadmap – The Credibility Gap Narrows, But Volatility Endures

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com